Sigma-Aldrich receives National Institutes of Health funding for cardiovascular disease research
Sigma Life Science to Analyze Plasma Samples from Framingham Heart Study in Researching Novel Biomarkers for Cardiovascular Disease
09-Aug-2010 -
Sigma-Aldrich® announced it has entered into an agreement with the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, and Boston University (BU) to develop methods to measure several potential biomarkers of atherosclerotic cardiovascular disease (CVD) using ...
biomarker
biomarkers
blood tests
+14